PCR Technologies Market
PCR Technologies Market by Technology (qPCR, dPCR, Multiplex, RT-PCR), Product (Instruments, Reagents & Consumables, Software), Application (Genotyping, Diagnostics, Environmental), End User (Hospital, Academia, Pharma-Biopharma) – Global forecast to 2031
PCR TECHNOLOGIES MARKET SIZE, SHARE & GROWTH SNAPSHOT
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global PCR technologies market is projected to grow from USD 15.55 billion in 2026 to USD 21.43 billion by 2031, at a CAGR of 6.6% during the forecast period. The market was valued at USD 14.80 billion in 2025. Advancements in qPCR technology are improving sensitivity, specificity, multiplexing, and workflow efficiency, while integration with digital PCR enables precise absolute quantification of nucleic acids. Increasing automation is improving consistency, reproducibility, scalability, and throughput, especially for high-volume workflows. Additionally, integration with NGS supports variant validation, gene expression analysis, and pathogen characterization. Real-time data analysis and cloud platforms are accelerating data processing, sharing, and collaboration, thereby broadening qPCR applications in research and clinical settings.
KEY TAKEAWAYS
-
MARKET SNAPSHOT:
Base Year Market Size (2025): USD 14.80 Billion
Current Market Size (2026): USD 15.55 Billion
Forecast Market Size (2031): USD 21.43 Billion
CAGR (2026–2031): 6.6% -
SEGMENT LEADERSHIP:
Regional Leader: North America accounted for the largest market share of 45% in 2025.
Product Leader: Reagents and consumables accounted for 65% of the market in 2025.
Fastest-Growing Technology: Digital PCR is projected to register the highest CAGR of 9.5% through 2031.
Application Leader: Diagnostic applications accounted for the largest market share in 2025.
End User Leader: Diagnostic laboratories accounted for the largest market share in 2025. -
MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad Laboratories, QIAGEN, and Agilent Technologies are among the leading PCR technology providers. Thermo Fisher holds a strong position in PCR instruments, while Roche leads the PCR reagents and consumables segment. Competitors are strengthening their positions through advanced qPCR, digital PCR, automation, and assay portfolios.
Emerging PCR companies are focusing on digital PCR, rapid PCR, automation, miniaturized systems, and highly sensitive molecular diagnostics, targeting applications in oncology, infectious disease detection, and decentralized testing.
The PCR technologies market is being driven by the increasing adoption of automated, high-throughput workflows that improve efficiency, reproducibility, scalability, and turnaround time, along with growing demand for multiplex PCR and advanced qPCR platforms that enable sensitive, specific, and simultaneous detection of multiple targets. The integration of digital PCR is further expanding applications requiring precise absolute quantification, while the growing use of PCR alongside NGS supports variant validation, gene expression analysis, and pathogen characterization. In addition, real-time data analysis, cloud-based platforms, and workflow automation are improving data processing, sharing, and collaboration, supporting broader adoption of PCR technologies across research and clinical applications.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The PCR technologies market is moving toward automated, standardized, and scalable molecular workflows, as hospitals and diagnostic laboratories seek higher testing throughput, greater accuracy and reproducibility, and faster time to results. Pharma-biotech companies are increasingly focused on supporting drug development, genetic analysis, and advanced applications such as digital PCR (dPCR) and multiplex PCR. These customer priorities are driving demand for decentralized and point-of-care testing, improved assay precision, rapid molecular results, and more efficient workflows, creating opportunities for new use cases, technologies, ecosystems, partnerships, and targeted M&A.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Increasing adoption of automated and high-throughput qPCR workflows
-
Development of miniaturized and portable point-of-care testing devices
Level
-
High equipment and operational costs
-
Dearth of skilled healthcare professionals
Level
-
Increased investments in laboratory infrastructure
-
Integration of qPCR with next-generation sequencing (NGS) and cloud-based data analysis
Level
-
Technical complexity and workflow limitations of advanced PCR platforms
-
Intensifying pricing pressure and competition among PCR technology providers
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Increasing adoption of automated and high-throughput qPCR workflows
Automation is improving consistency, reproducibility, and operational efficiency across qPCR workflows. Automated systems reduce manual pipetting, handling errors, and processing time, enabling laboratories to process hundreds or thousands of samples efficiently. Integration with automated data analysis further accelerates result generation, standardizes workflows, and improves laboratory productivity.
Restraint: High equipment and operational costs
Advanced real-time and digital PCR systems require significant upfront investment and ongoing expenses for reagents, consumables, maintenance, calibration, and system validation. These costs can be challenging for smaller laboratories and cost-sensitive healthcare settings, potentially slowing the adoption of advanced PCR platforms.
Opportunity: Integration of qPCR with next-generation sequencing (NGS) and cloud-based data analysis
Integrating qPCR with NGS can expand applications in variant validation, gene expression analysis, and pathogen characterization, while enabling more comprehensive molecular testing. Cloud-based platforms enable real-time data storage, analysis, and collaboration across laboratories, creating opportunities to improve workflow efficiency, scalability, data accessibility, and research capabilities.
Challenge: Technical complexity and workflow limitations of advanced PCR platforms
Advanced digital PCR and multiplex PCR systems require specialized expertise in assay design, sample preparation, data interpretation, and workflow management. Platform differences can complicate assay optimization, validation, and reproducibility, while the need for trained personnel and standardized workflows can make implementation more complex for laboratories.
PCR TECHNOLOGIES MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Supports pharmaceutical, university research, food, consumer, and diagnostic applications through PCR, qPCR, dPCR, reagents, and laboratory solutions | Enables high-throughput testing, precise molecular analysis, sample processing, and workflow efficiency |
 |
Provides PCR-based molecular diagnostic solutions for clinical testing, infectious disease detection, oncology, and decentralized diagnostics | Delivers automated, rapid, standardized, and high-volume molecular testing |
 |
Offers PCR, qPCR, and ddPCR systems, reagents, and consumables for research, diagnostics, biotechnology, and environmental applications | Supports sensitive detection, accurate quantification, reproducibility, and flexible PCR workflows |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The PCR technology ecosystem comprises manufacturers of reagents and consumables, instrument providers, end users, and regulatory bodies. Key suppliers include Thermo Fisher Scientific, Merck, Eppendorf, New England Biolabs, QIAGEN, Promega, Bio-Rad, and Agilent Technologies, while hospitals, diagnostic laboratories, and public health organizations are major end users. Regulatory oversight is supported by bodies such as the FDA, CDC, CDSCO, and China’s NMPA, which play an important role in ensuring the safety, performance, and compliance of PCR-based products and diagnostic solutions.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
PCR Technologies Market, By Product
Reagents and consumables accounted for the largest share of the PCR technologies market in 2025. Their recurring use across PCR workflows, including primers, probes, master mixes, polymerases, tubes, plates, and other consumables, supports consistent demand across research and diagnostic applications.
PCR Technologies Market, By Technique
Real-time PCR accounted for the largest share of the market, supported by its established use in quantitative molecular analysis, diagnostics, and research. Digital PCR is among the fastest-growing techniques, driven by demand for highly sensitive absolute quantification and rare-target detection.
PCR Technologies Market, By End User
Diagnostic laboratories accounted for the largest share of the market, driven by increasing molecular testing volumes and the widespread use of PCR for infectious disease, genetic, and oncology testing. The growing adoption of automated and high-throughput workflows is further supporting demand from diagnostic laboratories.
REGION
Asia Pacific is expected to register the fastest growth in the PCR technologies market during the forecast period
Asia Pacific is expected to register strong growth in the PCR technologies market, supported by expanding molecular diagnostics, increasing healthcare and laboratory infrastructure investments, and growing pharmaceutical and biotechnology R&D. Rising demand for infectious disease testing, genetic analysis, precision medicine, and point-of-care diagnostics is accelerating PCR adoption across the region. The increasing use of real-time PCR, digital PCR, automation, and high-throughput workflows, particularly across China, India, Japan, and South Korea, is further creating opportunities for PCR technology providers.
PCR TECHNOLOGIES MARKET: COMPANY EVALUATION MATRIX
The PCR technologies market is led by established players with broad portfolios spanning instruments, reagents, consumables, and molecular diagnostic solutions. Thermo Fisher Scientific is positioned as a Star, reflecting its strong product footprint and market position, while Abbott is positioned as an Emerging Leader, indicating a solid market presence and further potential to expand its PCR capabilities. Both companies are benefiting from growing demand for automated, high-throughput, real-time, and advanced molecular testing solutions, and continued product innovation and portfolio expansion are shaping their competitive positioning.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- F. Hoffmann-La Roche Ltd (Switzerland)
- Thermo Fisher Scientific Inc. (US)
- Danaher Corporation (US)
- Agilent Technologies, Inc. (US)
- Abbott (US)
- QIAGEN (Germany)
- Takara Bio Inc. (Japan)
- Bio-Rad Laboratories, Inc. (US)
- Analytik Jena GmbH+Co. KG (Germany)
- Merck KGaA (Germany)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 14.80 billion |
| Market Size in 2026 (Value) | USD 15.55 billion |
| Market Forecast in 2031 (value) | USD 21.43 billion |
| Growth Rate | CAGR of 6.6% from 2026–2031 |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD Billion) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Country Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
WHAT IS IN IT FOR YOU: PCR TECHNOLOGIES MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Pharmaceutical & Biotechnology Companies |
|
|
| Research & Academic Institutes |
|
|
RECENT DEVELOPMENTS
- June 2025 : QIAGEN entered into a strategic partnership with Tracer Biotechnologies (France) to develop blood-based companion diagnostics for solid tumors using QIAGEN’s QIAcuity digital PCR technology.
- June 2025 : QIAGEN partnered with GENCURIX (South Korea) to develop multiplex oncology IVD assays for tissue and liquid biopsy applications on QIAcuity digital PCR systems.
- May 2025 : QIAGEN partnered with ID Solutions (France) to expand QIAGEN’s oncology digital PCR assay portfolio, supporting multiplex mutation detection on QIAGEN’s QIAcuity digital PCR platforms.
- February 2025 : Bio-Rad Laboratories agreed to acquire Stella Technologies (France) to expand its digital PCR portfolio and strengthen its capabilities in automated, high-throughput digital PCR workflows.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
The PCR technologies market size was estimated through a combination of extensive secondary and primary research, followed by data validation and triangulation. Secondary research drew on company reports, financial filings, industry databases, publications, and other credible sources to assess market structure, the competitive landscape, product offerings, and industry trends. Primary research involved interviews with supply- and demand-side stakeholders to validate market assumptions, pricing trends, adoption patterns, and market estimates. Top-down and bottom-up approaches, market segmentation, and data triangulation were used to develop market estimates across key segments, regions, and countries.
Secondary Research
Secondary research drew on company annual reports, SEC filings, investor presentations, industry databases, white papers, company websites, and relevant industry publications. These sources informed analysis of company revenues, product portfolios, market positioning, technological developments, and market trends across the PCR technologies ecosystem.
Primary Research
Primary research included both supply-side and demand-side participants. Supply-side interviews involved senior executives, sales and marketing leaders, product managers, and regional representatives from PCR technology providers. Demand-side discussions involved diagnostic laboratories, hospitals, research institutions, pharmaceutical and biotechnology companies, and other PCR technology users. The findings were used to validate market-sizing assumptions, purchasing patterns, technology adoption, and key market drivers and restraints.
A breakdown of the primary respondents is provided below:
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = <USD 500 million, and Tier 3 = <USD 100 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
This research involves a revenue-sharing review of the leading players in the PCR technologies market. Primary and secondary research methods were used to identify key players in the industry and to gain a basic understanding of their financial performance and market share. Primary research consisted of more detailed interviews with CEOs, directors, and senior marketing executives, whereas secondary research relied primarily on annual and financial reports issued by the major players in the industry. A segment-based strategy was used to determine market value across the globe, and the revenue details of the leading solution providers were further used to differentiate between sources and services.
Procedures Covered:
Identify the companies around the world that are leading the PCR technologies industry and note their respective annual revenues or specific product category/business division.
The revenue mapping of the key competitors, based on 2024, represents a major share of the market for this analysis and is thus extrapolated to the total global value for the PCR technologies market.
PCR Technologies Market : Top-Down and Bottom-Up Approach
Data Triangulation
The PCR technologies market is segmented into segments and subsegments based on the methodology adopted in this report. Data triangulation and the segmentation process are then undertaken to ensure the accuracy of data for all segments. Drivers and trends have been identified from both the supply and demand sides. The results obtained from both the top-down and bottom-up approaches have been used to derive the results of the PCR technologies market analysis.
Market Definition
The PCR (Polymerase Chain Reaction) technologies market spans the biotechnology and healthcare industries, offering products and services related to PCR techniques. PCR is a molecular biology technique that enables targeted amplification of DNA sequences, allowing genetic material to be examined. This market encompasses several subcomponents, including equipment such as thermal cyclers and real-time PCR machines, and consumables such as reagents, enzymes, primers, and kits for PCR. Applications of PCR include research, clinical diagnostics, genetic testing, forensic analysis, and environmental studies. Key drivers of this market include technological advances, such as digital PCR and multiplex PCR, which improve instrument sensitivity and specificity. Future growth is expected due to increased research activity, a rising incidence of genetic disorders, and ongoing innovation in biotechnology.
Key Stakeholders
- Manufacturers and distributors of PCR technology devices
- Healthcare institutions (hospitals and clinics)
- Diagnostic centers
- Healthcare institutions (hospital labs)
- Research institutions
- Research and consulting firms
- Contract research organizations (CROs) and contract manufacturing organizations (CMOs)
- Academic medical centers and universities
- Market research and consulting firms
- Clinical research organizations
- Pharma-biotech companies
- Group purchasing organizations (GPOs)
- Medical research laboratories
- Academic medical centers and universities
- Accountable care organizations (ACOs)
Report Objectives
- To define, describe, and forecast the global PCR technologies market based on product, application, technique, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To profile the key market players and comprehensively analyze their market share and core competencies2
- To forecast the revenue of the market segments in five main regions: North America (the US and Canada), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), the Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa (GCC Countries and the Rest of Middle East & Africa)
- To track and analyze competitive developments such as product launches and approvals, agreements, partnerships, expansions, acquisitions, and collaborations in the PCR technologies market
Available customizations:
With the market data, MarketsandMarkets offers customizations as per the company’s requirements. The following customization options are available for the global PCR technologies market
Product Analysis
- Product matrix, which compares product portfolios of the top 5 companies.
Company Information
- In-depth profiling of additional market players (up to 5)
Geographic Analysis
-
Further breakdown of the Rest of Europe's PCR technologies market: Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal among other
-
Further breakdown of the Rest of Asia Pacific PCR technologies market Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
-
Further breakdown of the Rest of Latin America PCR technologies market Argentina, Chile, Columbia and among others
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the PCR Technologies Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free CustomisationTESTIMONIALS
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Companywww.sfihealth.com/
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Companywww.qualicaps.com/
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnosticsimaging.bracco.com/us-en
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.www.3m.com/3M/en_US/health-information-systems-us
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
- Canada PCR Technologies Market
- US PCR Technologies Market
- Germany PCR Technologies Market
- France PCR Technologies Market
- UK PCR Technologies Market
- Italy PCR Technologies Market
- Spain PCR Technologies Market
- China PCR Technologies Market
- Japan PCR Technologies Market
- India PCR Technologies Market
- Australia PCR Technologies Market
- South Korea PCR Technologies Market
- Brazil PCR Technologies Market
- Mexico PCR Technologies Market
- Rest Of Europe PCR Technologies Market
- Rest Of Asia Pacific PCR Technologies Market
- Rest Of Latin America PCR Technologies Market
Growth opportunities and latent adjacency in PCR Technologies Market